NCT03713437View on ClinicalTrials.gov

Measurement of Beta Cell Death in Individuals With Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Cystic Fibrosis-related Diabetes
Interventions
DIAGNOSTIC_TEST

Measurement of differentially methylated insulin DNA

A serum sample will be drawn to measure differentially methylated insulin DNA.

Trial Locations (1)

68114

Children's Hospital and Medical Center, Omaha

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

University of Nebraska

OTHER

NCT03713437 - Measurement of Beta Cell Death in Individuals With Cystic Fibrosis | Biotech Hunter | Biotech Hunter